Potential impact of introducing a nonavalent HPV vaccination. Int J Gynaecol Obstet

Bogani G, Taverna F, Lombardo C, Signorelli M, Chiappa V, Casarin J, Scaffa C, Leone Roberti Maggiore U, Recalcati D, Ditto A, Martinelli F, Borghi C, Perotto S, Ferrero S, Lorusso D, Raspagliesi F. Potential impact of introducing a nonavalent HPV vaccination. Int J Gynaecol Obstet 2018;142:338-342. https://obgyn.onlinelibrary.wiley.com/doi/abs/10.1002/ijgo.12546

Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis.

Barra F, Scala C, Ferrero S. Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis. Expert Opin Drug Metab Toxicol 2018;14:399-415. https://www.tandfonline.com/doi/abs/10.1080/17425255.2018.1461840?journalCode=iemt20

Cardiovascular effects of antimuscarinic agents and beta3-adrenergic receptor agonist for the treatment of overactive bladder.

Rosa GM, Baccino D, Valbusa A, Scala C, Barra F, Brunelli C, Ferrero S. Cardiovascular effects of antimuscarinic agents and beta3-adrenergic receptor agonist for the treatment of overactive bladder. Expert Opin Drug Saf 2018;17:487-497. https://www.tandfonline.com/doi/abs/10.1080/14740338.2018.1453496?journalCode=ieds20